Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Noevir Holdings Co., Ltd. ( (JP:4928) ).
Noevir Holdings Co., Ltd. has announced changes in the leadership of its subsidiaries, Noevir Co., Ltd. and TOKIWA Pharmaceutical Co., Ltd., as part of a management restructuring. These changes, which will be finalized at upcoming shareholder and board meetings, aim to streamline operations and enhance strategic focus across various divisions, potentially impacting the company’s market positioning and stakeholder interests.
The most recent analyst rating on (JP:4928) stock is a Buy with a Yen4823.00 price target. To see the full list of analyst forecasts on Noevir Holdings Co., Ltd. stock, see the JP:4928 Stock Forecast page.
More about Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. operates in the cosmetics and pharmaceuticals industry, focusing on beauty and healthcare products. The company is listed on the Tokyo Stock Exchange and is known for its innovative research and development in cosmetics and health-related products.
Average Trading Volume: 121,303
Technical Sentiment Signal: Hold
Current Market Cap: Yen150.6B
See more data about 4928 stock on TipRanks’ Stock Analysis page.